Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $77.0600 (0.34%) ($76.6600 - $78.1700) on Wed. Jun. 5, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.07% (three month average) | RSI | 43 | Latest Price | $77.0600(0.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.3% a day on average for past five trading days. | Weekly Trend | ABBV declines -2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(60%) DIA(50%) VYM(50%) IVE(49%) SPLV(49%) | Factors Impacting ABBV price | ABBV will decline at least -0.535% in a week (0% probabilities). VXX(-15%) TLT(-15%) IFRA(-11%) IGOV(-3%) UUP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.535% (StdDev 1.07%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
1 - 5 Day Possible Target | $73.33(-4.84%) | Resistance Level | $78.47 | 5 Day Moving Average | $76.78(0.36%) | 10 Day Moving Average | $78.16(-1.41%) | 20 Day Moving Average | $78.47(-1.8%) | To recent high | -8.2% | To recent low | 1.8% | Market Cap | $135.956b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |